These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 22961234)
1. The effect of the contents of exomphalos and nuchal translucency at 11-14 weeks on the likelihood of associated chromosomal abnormality. Iacovella C; Contro E; Ghi T; Pilu G; Papageorghiou A; Thilaganathan B; Bhide A Prenat Diagn; 2012 Nov; 32(11):1066-70. PubMed ID: 22961234 [TBL] [Abstract][Full Text] [Related]
2. Outcome of fetal exomphalos diagnosed at 11-14 weeks of gestation. Khalil A; Arnaoutoglou C; Pacilli M; Szabo A; David AL; Pandya P Ultrasound Obstet Gynecol; 2012 Apr; 39(4):401-6. PubMed ID: 21793081 [TBL] [Abstract][Full Text] [Related]
3. Impact of holoprosencephaly, exomphalos, megacystis and increased nuchal translucency on first-trimester screening for chromosomal abnormalities. Syngelaki A; Guerra L; Ceccacci I; Efeturk T; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Jul; 50(1):45-48. PubMed ID: 27558969 [TBL] [Abstract][Full Text] [Related]
4. Fetal nuchal translucency scan and early prenatal diagnosis of chromosomal abnormalities by rapid aneuploidy screening: observational study. Chitty LS; Kagan KO; Molina FS; Waters JJ; Nicolaides KH BMJ; 2006 Feb; 332(7539):452-5. PubMed ID: 16476673 [TBL] [Abstract][Full Text] [Related]
5. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of impending fetal death. Spencer K; Cowans NJ; Avgidou K; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Oct; 28(5):637-43. PubMed ID: 16952214 [TBL] [Abstract][Full Text] [Related]
6. The added value of detailed early anomaly scan in fetuses with increased nuchal translucency. Zalel Y; Zemet R; Kivilevitch Z Prenat Diagn; 2017 Mar; 37(3):235-243. PubMed ID: 28010037 [TBL] [Abstract][Full Text] [Related]
7. Male-to-female gender ratio in fetuses with increased nuchal translucency. Daouk ME; Brustman L; Langer O; Lysikiewicz A J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2613-5. PubMed ID: 22725674 [TBL] [Abstract][Full Text] [Related]
8. Low-resistance hepatic artery flow in first-trimester fetuses: an ominous sign. Bilardo CM; Timmerman E; De Medina PG; Clur SA Ultrasound Obstet Gynecol; 2011 Apr; 37(4):438-43. PubMed ID: 20922779 [TBL] [Abstract][Full Text] [Related]
9. Estimation of Detection Rates of Aneuploidy in High-Risk Pregnancy Using an Approach Based on Nuchal Translucency and Non-Invasive Prenatal Testing: A Cohort Study. Khalil A; Mahmoodian N; Kulkarni A; Homfray T; Papageorghiou A; Bhide A; Thilaganathan B Fetal Diagn Ther; 2015; 38(4):254-61. PubMed ID: 25925597 [TBL] [Abstract][Full Text] [Related]
10. First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery. Spencer K; Cowans NJ; Molina F; Kagan KO; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Feb; 31(2):147-52. PubMed ID: 17992705 [TBL] [Abstract][Full Text] [Related]
11. Identification of submicroscopic chromosomal aberrations in fetuses with increased nuchal translucency and apparently normal karyotype. Leung TY; Vogel I; Lau TK; Chong W; Hyett JA; Petersen OB; Choy KW Ultrasound Obstet Gynecol; 2011 Sep; 38(3):314-9. PubMed ID: 21400624 [TBL] [Abstract][Full Text] [Related]
12. Sonographic screening for trisomy 13 at 11 to 13(+6) weeks of gestation. Papageorghiou AT; Avgidou K; Spencer K; Nix B; Nicolaides KH Am J Obstet Gynecol; 2006 Feb; 194(2):397-401. PubMed ID: 16458636 [TBL] [Abstract][Full Text] [Related]
13. By how much does increased nuchal translucency increase the risk of adverse pregnancy outcome in chromosomally normal fetuses? A study of 16,260 fetuses derived from an unselected pregnant population. Westin M; Saltvedt S; Almström H; Grunewald C; Valentin L Ultrasound Obstet Gynecol; 2007 Feb; 29(2):150-8. PubMed ID: 17211897 [TBL] [Abstract][Full Text] [Related]
14. First-trimester sonography of physiological midgut herniation and early diagnosis of omphalocele. van Zalen-Sprock RM; Vugt JM; van Geijn HP Prenat Diagn; 1997 Jun; 17(6):511-8. PubMed ID: 9203209 [TBL] [Abstract][Full Text] [Related]
15. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks. Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277 [TBL] [Abstract][Full Text] [Related]
17. Nuchal translucency as a method of first-trimester screening for aneuploidy. Naidoo P; Erasmus I; Jeebodh J; Nicolaou E; van Gelderen CJ S Afr Med J; 2008 Apr; 98(4):295-9. PubMed ID: 18637640 [TBL] [Abstract][Full Text] [Related]
18. Nuchal translucency distributions for different chromosomal anomalies in a large unselected population cohort. Christiansen M; Ekelund CK; Petersen OB; Hyett J; Eastwood N; Ball S; Tabor A; Vogel I Prenat Diagn; 2016 Jan; 36(1):49-55. PubMed ID: 26505467 [TBL] [Abstract][Full Text] [Related]
19. First-trimester biochemical markers of aneuploidy and the prediction of small-for-gestational age fetuses. Spencer K; Cowans NJ; Avgidou K; Molina F; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Jan; 31(1):15-9. PubMed ID: 17999381 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness. Tekesin I J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]